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Abstract
Background: During the initial phase of critical illness, the association between the dose of nutrition support and
mortality risk may vary among patients in the intensive care unit (ICU) because the prevalence of malnutrition
varies widely (28 to 78%), and not all ICU patients are severely ill. Therefore, we hypothesized that a prognostic
model that integrates nutritional status and disease severity could accurately predict mortality risk and classify
critically ill patients into low- and high-risk groups. Additionally, in critically ill patients placed on exclusive
nutritional support (ENS), we hypothesized that their risk categories could modify the association between dose of
nutrition support and mortality risk.
Methods: A prognostic model that predicts 28-day mortality was built from a prospective cohort study of 440
patients. The association between dose of nutrition support and mortality risk was evaluated in a subgroup of 252
mechanically ventilated patients via logistic regressions, stratified by low- and high-risk groups, and days of
exclusive nutritional support (ENS) [short-term (≤ 6 days) vs. longer-term (≥ 7 days)]. Only the first 6 days of ENS was
evaluated for a fair comparison.
Results: The prognostic model demonstrated good discrimination [AUC 0.78 (95% CI 0.73–0.82), and a bias-corrected
calibration curve suggested fair accuracy. In high-risk patients with short-term ENS (≤ 6 days), each 10% increase in goal
energy and protein intake was associated with an increased adjusted odds (95% CI) of 28-day mortality [1.60 (1.19–
2.15) and 1.47 (1.12–1.86), respectively]. In contrast, each 10% increase in goal protein intake during the first 6 days of
ENS in high-risk patients with longer-term ENS (≥ 7 days) was associated with a lower adjusted odds of 28-day
mortality [0.75 (0.57–0.99)]. Despite the opposing associations, the mean predicted mortality risks and prevalence of
malnutrition between short- and longer-term ENS patients were similar.
Conclusions: Combining baseline nutritional status and disease severity in a prognostic model could accurately
predict 28-day mortality. However, the association between the dose of nutrition support during the first 6 days of ENS
and 28-day mortality was independent of baseline disease severity and nutritional status.
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Background
The optimal daily amounts of energy and protein that re-
sult in a lower mortality risk in critically ill patients remain
uncertain. Heyland et al. [1] proposed that nutritional
support may not benefit all patients and consequently de-
veloped the Nutrition Risk in Critically Ill score (NUTRIC)
to identify patients who would derive the most benefit from
nutritional support. This score was subsequently modified
to exclude interleukin-6 [modified-NUTRIC (mNUTRIC)]
and currently comprises variables such as age, Acute Physi-
ology and Chronic Health Evaluation II score, Sequential
Organ Failure Assessment (SOFA) score, length of
hospitalization before admission to the intensive care unit
(ICU), and number of comorbidities [2]. None of these is
nutritional parameters, and it is arguable that the mNU-
TRIC is a disease severity score. This concept is supported
by data from a study by Lew et al. [3] wherein a poor con-
cordance was demonstrated between the mNUTRIC score
and the Subjective Global Assessment (SGA)—a validated
nutritional assessment tool that has strong mortality prog-
nostic value in critically ill patients [4, 5].
The mNUTRIC has a maximum score of 9, in which
the scores 0 to 4 and 5 to 9 are classified as low-
mNUTRIC and high-mNUTRIC, respectively. Adequate
energy and protein intakes were observed to benefit only
high-mNUTRIC patients, with no effect on low-
mNUTRIC patients [2, 6, 7]. However, several recent
studies have reported conflicting results [8, 9]. Lew et al.
[10] recently validated the mNUTRIC score and ob-
served that the association between mNUTRIC score
and 28-day mortality was modified by the timing and
dose of nutritional support [10]. Specifically, the study
suggested that early high energy and protein intakes
were associated with a higher risk of 28-day mortality in
high-mNUTRIC patients with short-term nutritional
support (≤ 6 days), whereas the inverse was observed in
those with longer-term nutritional support (≥ 7 days)
[10]. However, the median mNUTRIC scores of these
two groups of patients (receiving ≤ 6 days vs. ≥ 7 days of
nutritional support) at ICU admission were similar,
which suggested that the associations between early high
energy and protein intakes and 28-day mortality were
not modified by baseline disease severity measured by
the mNUTRIC score.
It is unclear if the above results reflect the absence of
nutritional parameters in the mNUTRIC score because
intuitively, malnourished patients would be expected to
require more energy and protein to overcome the
deleterious effects of critical illness. Lew et al. [3] previ-
ously demonstrated that disease severity (measured by
the mNUTRIC) and nutritional status (measured by the
SGA) independently and in combination can predict
mortality [3, 4]. A recent review also recommends
simultaneous use of both the mNUTRIC and SGA for
complete nutritional evaluation for the critically ill [11].
In light of this, we aimed to develop a new prognostic
model, namely the Global Index of Mortality Probability
in the Severely ill (GLIMPSE) that combines both mNU-
TRIC and 7-point SGA to classify patients into low- and
high-risk of 28-day mortality (low-GLIMPSE and high-
GLIMPSE, respectively). In addition, we evaluated
whether GLIMPSE categories could modify the associ-
ation between dose of nutrition support during the first
6 days of exclusive nutritional support (ENS) and 28-day
mortality in a single-centre cohort study.
Methods
Setting and patients
This was a prospective observational cohort study con-
ducted in the ICU (35 beds) of Ng Teng Fong General
Hospital (Singapore). The ICU functions as a closed
unit, in which board-certified intensivists and residents
provide care for medical, surgical, trauma, cardiac, and
neurological patients. The intensivists and nurses were
blinded to the objective of the study. Patients are classi-
fied as “critically ill” if they are mechanically ventilated
and require the support of two or more organ systems.
They are downgraded to high dependency status once
they are extubated from mechanical ventilation.
To develop GLIMPSE, consecutive patients admitted
between August 2015 and October 2016 were screened
for enrolment. Patients who were at least 21 years old,
had been admitted to the ICU at least 24 h prior to the
screening, and whose nutritional status was established
within 48 h were enrolled. Nutritional status was estab-
lished by the 7-point SGA, and details have been previ-
ously published [4]. Briefly, each 1 point decrease in the
7-point SGA (indicative of a greater degree of malnutri-
tion) was associated with a higher risk of 28-day mortal-
ity [4]. Patients who were readmitted to the ICU within
the same hospitalization were excluded.
The modifying effects of GLIMPSE categories on the
association between the dose of nutrition support during
the first 6 days of ENS and 28-day mortality were evalu-
ated in a subgroup of patients. These patients had experi-
enced at least 48 h of mechanical ventilation and were not
pronounced moribund (had medical orders not to resusci-
tate or had poor prognosis) within 48 h of ICU admission.
The Domain Specific Review Board approved this
study (NHG DSRB Ref: 2014/00878), and informed
consent was not required because no attempt was made
to change the standard of care in the study.
Data collection
Patient demographics, admission diagnoses, adequacy of
exclusive nutritional support (ENS), and mortality
outcome were prospectively recorded in the electronic
medical records and retrieved. Since mNUTRIC was not
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part of routine care, it was calculated at the end of the
study. Details of the collection of energy and protein in-
takes via ENS have been previously published [10].
Briefly, adequacy of nutritional support was calculated
by dividing the total enteral and/or parenteral nutrition
(energy and protein) intake as well as energy provided
by propofol and intravenous dextrose by a number of
days on ENS and expressed as a percentage of the goals
established at ICU admission. This information was re-
corded from ICU admission to a maximum of 14 days,
unless death occurred earlier.
Development of GLIMPSE
Variables demonstrated to be associated with mortality
outcomes in our previous studies were included in
GLIMPSE. These comprised the following: (1) disease
severity, as measured by the mNUTRIC score [3]; (2)
nutritional status, as measured by the 7-point SGA [4];
and (3) cardiopulmonary resuscitation before ICU
admission [4]. As there were three predictors, it was
estimated that the model required at least 74 events
(deaths) in order to ensure model stability [12]. The
three predictors were fitted into a multivariable logistic
model to predict 28-day mortality. This generated
weighted coefficients and a constant that could be used
to calculate the predicted mortality risk of patients.
More importantly, a logistic model is required for the
measurement of internal validity. The internal validity of
GLIMPSE was assessed via a bootstrapping technique, in
which 1000 re-samples of the entire cohort were created
to quantify the discrimination and calibration accuracy
of GLIMPSE (R package version 3.5.1. http://CRAN.R-
project.org/package=rms). Discrimination was assessed
by using the C-index (adjusted for optimism via boot-
strapping). Calibration was assessed graphically by pre-
paring a bias-corrected calibration curve and assessing
its slope.
Validity of GLIMPSE as an assessment tool for nutritional
support
Lew et al. [10] showed that the associations between
early high energy and protein intakes and 28-day mortal-
ity in high-mNUTRIC patients with ≤ 6 days and ≥ 7
days of ENS were different (increased mortality risk vs.
reduced mortality risk, respectively) and the mNUTRIC
of these two groups of patients were similar [10]. We
adopted the same method used in the earlier study to
determine the validity of GLIMPSE in the same sub-
group of patients. First, the mortality risks of patients
predicted by GLIMPSE were stratified into low- and
high-GLIMPSE by using the Youden Index [13]. Second,
multivariable logistic regressions were used to determine
the associations between energy and protein adequacies
and 28-day mortality, stratified by GLIMPSE risk groups
and the duration of ENS exposure (≤ 6 days and ≥ 7
days). To avoid multicollinearity, covariate adjustment
was not carried out on variables used to calculate the
mNUTRIC score [6]. Statistical analyses were performed
using STATA 14.2 (Stata Corp., College Station, TX,
USA) and R package (version 3.5.1). For all comparisons,
interactions, and associations, a p value < 0.05 was con-
sidered statistically significant.
Results
There were 440 patients enrolled, and no patients were
lost to follow-up (Fig. 1). Mortality at day 28 following
ICU admission was 28.0%. Survivors had lower disease
severity and were more likely to be well-nourished com-
pared to nonsurvivors (Table 1). Data from a subgroup
of 252 patients were used to evaluate the modifying
effects of GLIMPSE categories on the association
between the dose of energy and protein intakes during
the first 6 days of ENS and 28-day mortality. Patients
who were excluded had similar characteristics to those
included in the validation group apart from a lower
SOFA score (mean, 8.1 vs. 9.2, p < 0.001) and a higher
number of comorbidities (median, 3 vs. 2, p < 0.001).
The characteristics of the 252 patients were stratified by
their duration of exposure to ENS (short- vs. longer-term
ENS). The characteristics of patients with short- and
longer-term ENS were similar except for the type of admis-
sion, number of comorbidities, and admission diagnosis.
The mean (SD) percentages of energy and protein
relative to the requirements for the first 6 days of ICU
admission in the validation group were 60.0% (23.6%)
[15.2 (6.5) kcal/kg] and 55.1% (24.5%) [0.64 (0.31) g/kg],
respectively. The actual energy and protein intakes are
summarized in Table 2. During the first 6 days of ENS,
patients with longer-term ENS had significantly higher
energy and protein intakes than those of the patients
with short-term ENS (p value < 0.001 for both energy
and protein). When stratified by nutritional status, the
mean percentages of goal energy and protein intakes be-
tween the well-nourished and malnourished patients
during the first 6 days of ENS (energy, 63.4% vs. 58.8%,
p = 0.172; protein, 57.4% vs. 54.2%, p = 0.368, respect-
ively) were not signficantly different.
Development of GLIMPSE
The mNUTRIC score, 7-point SGA, and exposure to
cardiopulmonary resuscitation before ICU admission
were fitted into a multivariable logistic regression, and
they were significantly associated with 28-day mortality
(refer to Additional file 1 for regression parameters).
The resultant equation used to calculate the predicted
28-day mortality risk was − 3.003 + (mNUTRIC × 0.477)
+ (7-point SGA × − 0.166) + (exposure to cardiopulmo-
nary resuscitation before ICU admission × 1.933).
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Internal validation in the model via 1000 bootstrap repli-
cates revealed an adjusted C-index and max-rescaled R2
of 0.78 (95% CI 0.73–0.82) and 0.30, respectively. The
bias-corrected calibration curve (Fig. 2) suggested overall
fair calibration accuracy (slope, 0.98).
Validity of GLIMPSE as an assessment tool for nutritional
support
The optimal cutoff point for defining low- and high-
GLIMPSE was 20%, and the C-index, sensitivity, and
specificity were 0.71, 87.8%, and 54.6%, respectively. The
characteristics of patients classified as low- and high-
GLIMPSE on the first day of ICU admission were all
significantly different except for sex and body mass
index (Table 3). However, the mean predicted mortality
risks (standard deviation) in patients with short- and
longer-term ENS were similar [32.2% (24.1%) vs. 27.8%
(21.3%), respectively, p = 0.122].
Several covariates were not adjusted in the multivari-
able logistic model. Firstly, location before ICU admis-
sion and types of admission were not adjusted although
they were significantly associated with mortality at the
univariate level (Table 1). When included in a multivari-
able model (along with GLIMPSE group, adequacy of
energy and protein intake, and duration of ENS), these
covariates were not significantly associated with mortal-
ity (refer to Additional file 1). Secondly, since the
duration of ENS was correlated with the duration of
mechanical ventilation (r = 0.82) and ICU length of stay
(r = 0.67), only the duration of ENS was included in the
multivariable logistic model [14]. Lastly, time to initi-
ation of enteral feeding was not adjusted because our
ICU nutrition policy requires patients to receive enteral
nutrition support within 48 h of ICU admission. There-
fore, only 12 patients were not enterally fed within 48 h
of ICU admission. This resulted in an insignificant asso-
ciation with mortality (p = 0.416).
In patients with short-term ENS, the associations be-
tween energy and protein intakes and 28-day mortality
during the first 6 days of ENS were examined in multivari-
able logistic regression models (Table 4). There were no
interactions between the GLIMPSE groups and energy
and protein intakes. Generally, there was a positive associ-
ation between energy and protein intakes and 28-day mor-
tality in both GLIMPSE groups, but it was statistically
significant for patients with high-GLIMPSE only.
Similarly, the association between energy and protein
intakes and 28-day mortality during the first 6 days of
ENS was examined in patients with longer-term ENS
(Table 4). There were significant interactions between
the GLIMPSE groups and energy and protein intakes.
The associations between energy and protein intakes
and 28-day mortality in patients with low- and high-
GLIMPSE appeared to be opposite of each other, but
only protein intake was significantly associated with 28-
day mortality because each 10% increase in protein
adequacy was associated with a 25% reduction in the
odds of 28-day mortality.
Discussion
A new prognostic model (GLIMPSE) was developed by
combining baseline nutritional status (measured by the
7-point SGA) and disease severity (measured by the
mNUTRIC score) to predict 28-day mortality. Internal
validation suggested that GLIMPSE had good discrimin-
ation and calibration accuracy and was able to identify
patients at low and high risk of 28-day mortality.
However, the mortality risk established by GLIMPSE did
not explain the lack of association between the dose of
nutrition support during the first 6 days of ENS and 28-
day mortality.
Fig. 1 Enrolment of patients
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Prognostic performance
The GLIMPSE model can be viewed as an extension of
the mNUTRIC score. The latter had a C-index and max-
rescaled R2 of 0.65 and 0.57, respectively [2]. However,
subsequent large multicentre cohort studies (n > 1000)
that sought to validate mNUTRIC demonstrated re-
duced prognostic performance, with the C-index and
max-rescaled R2 ranging from 0.65 to 0.7 and from 0.09
to 0.16, respectively [6, 15]. In our study, the GLIMPSE
model demonstrated better prognostic performance than
that of the mNUTRIC. This may be attributed to the
inclusion of strong independent predictors of mortality
(nutritional status and CPR) [4]. Despite its good prog-
nostic performance, the GLIMPSE model was unable to
explain the lack of association between early high energy
and protein intakes and 28-day mortality.
Validity of GLIMPSE as an assessment tool for nutritional
support
The prevalence of malnutrition in the ICU reportedly
ranges from 28 to 78% [4]. Urgent nutritional support,
which often translates to early high energy and protein
Table 1 Characteristics of the enrolled patients
Patient
characteristics
Enrolled patients
(n = 440)
Survivors
(n = 317)
Nonsurvivors
(n = 123)
p value Short-term ENS
(≤ 6 days) (n = 106)
Longer-term ENS
(≥ 7 days) (n = 146)
p value
Age (years) 61.4 (15.7) 59.3 (15.9) 66.8 (14.1) < 0.001 60.4 (16.9) 59.5 (15.5) 0.655
Male 259 [58.9] 192 [60.6] 67 [54.5] 0.244 63 [59.4] 92 [63.0] 0.564
BMI (kg/m2) 24.4 [21.3, 28.2] 24.4 [21.2, 28.0] 24.2 [21.3, 28.6] 0.955 24.5 [21.2, 29.5] 24.6 [21.8, 28.4] 0.726
Location before adm. 0.003 0.976
ED/HD/OT 357 [81.1] 268 [84.5] 89 [72.4] 88 [83.0] 121 [82.9]
Wards 83 [18.9] 49 [15.5] 34 [27.6] 18 [17.0] 25 [17.1]
Type of adm. 0.006 0.001
Medical 293 [66.6] 199 [62.8] 94 [76.4] 80 [75.5] 79 [54.1]
Surgery 147 [33.4] 118 [37.2] 29 [23.6] 26 [24.5] 67 [45.9]
Number of comorbidities 2.0 [1.0, 4.0] 2.0 [1.0, 4.0] 3.0 [2.0, 4.0] 0.069 3.0 [1.0, 4.0] 2.0 [1.0, 3.0] 0.002
LOS before ICU adm. (days) 0.0 [0.0, 1.0] 0.0 [0.0, 1.0] 1.0 [0.0, 3.0] 0.009 0.0 [0.0, 1.3] 0.0 [0.0, 1.3] 0.730
APACHE II 24.5 (8.1) 22.6 (7.4) 29.5 (7.7) < 0.001 25.4 (8.4) 24.7 (7.6) 0.543
SOFA 8.7 (3.8) 7.9 (3.5) 10.7 (3.8) < 0.001 9.2 (3.7) 9.1 (3.8) 0.909
mNUTRIC 5.3 (2.1) 4.8 (2.1) 6.6 (1.5) < 0.001 5.5 (2.3) 5.3 (2.0) 0.531
mNUTRIC≥ 5 299 [68.0] 187 [59.0] 112 [91.1] < 0.001 74 [69.8] 100 [68.5] 0.823
Malnutrition 123 [28.0] 72 [22.7] 51 [41.5] < 0.001 31 [29.2] 35 [24.0] 0.347
Admission reasons < 0.001 0.020
Cardiovascular 82 [18.6] 43 [13.6] 39 [31.7] 19 [17.9] 18 [12.3]
Respiratory 84 [19.1] 68 [21.5] 16 [13.0] 24 [22.6] 21 [14.4]
Sepsis 105 [23.9] 72 [22.7] 33 [26.8] 36 [34.0] 39 [26.7]
Trauma 12 [2.7] 12 [3.8] 0 [0.0] 4 [3.3] 4 [2.7]
Metabolic/renal 8 [1.8] 8 [2.5] 0 [0.0] 2 [1.9] 2 [1.4]
Gastrointestinal 42 [9.6] 29 [9.2] 13 [10.6] 3 [2.8] 8 [5.5]
Postoperation 13 [3.0] 12 [3.8] 1 [0.8] 4 [3.8] 3 [2.1]
Orthopaedics 7 [1.6] 6 [1.9] 1 [0.8] 1 [0.9] 2 [1.4]
Neurological 87 [19.8] 67 [21.1] 20 [16.3] 13 [12.3] 49 [33.6]
CPR before ICU adm. 53 [12.1] 17 [5.4] 36 [29.3] < 0.001 18 [17.0] 18 [12.3] 0.297
Length of MV (days) 2.0 [1.0, 5.0] 2.0 [1.0, 4.0] 3.0 [2.0, 6.0] < 0.001 3.0 [2.0, 4.0] 7.0 [4.0, 13.0] < 0.001
ICU LOS (days) 2.0 [2.0, 5.0] 2.0 [1.0, 4.0] 3.0 [2.0, 6.0] 0.001 3.0 [2.0, 4.0] 7.0 [4.0, 12.0] < 0.001
Hospital LOS (days) 14.0 [7.0, 25.0] 15.0 [9.0, 33.0] 9.0 [4.0, 16.0] < 0.001 8.0 [4.0, 15.3] 24.0 [16.0, 45.0] < 0.001
Values are mean (standard deviation), median [Q1, Q3], or count [percentage]
Adm. admission, APACHE II Acute Physiology and Chronic Health Evaluation II, BMI body mass index, CPR cardiopulmonary resuscitation, ED emergency
department, ENS exclusive nutritional support, HD high dependency, ICU intensive care unit, LOS length of stay, MV mechanical ventilation, mNUTRIC Modified
Nutrition Risk in Critically Ill, OT operation theatre, SOFA Sequential Organ Failure Assessment
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intakes, is recommended for malnourished critically ill
patients because it confers clinical benefits [16, 17]. To
our knowledge, this has not been examined in random-
ized controlled trials performed in ICUs because this
subgroup of patients is often excluded for ethical
reasons. When examined in the subgroup or post hoc
analyses, patients at risk of malnutrition did not benefit
from higher energy and protein intakes [18, 19]. Given
the paucity of evidence, our prospective observational
study may help in bridging this knowledge gap, i.e.
Table 2 Comparison of goal and achieved energy and protein intakes between 28-day survivors and nonsurvivors stratified by days
of exclusive nutritional support
Nutritional parameters All patients Survivors Nonsurvivors p value
Short-term exclusive nutritional support (≤ 6 days)
Energy
Goal (kcal/kg) 25.7 (5.8) 25.5 (5.5) 25.9 (6.3) 0.680
Actual intake (kcal/kg) 12.0 (6.6) 10.0 (6.0) 15.0 (6.4) < 0.001
Actual intake (% goal/kg) 48.0 (24.9) 40.0 (22.4) 59.2 (24.1) < 0.001
Protein
Goal (g/kg) 1.14 (0.23) 1.14 (0.20) 1.15 (0.26) 0.779
Actual intake (g/kg) 0.47 (0.29) 0.39 (0.26) 0.57 (0.30) 0.001
Actual intake (% goal/kg) 41.6 (25.0) 34.7 (21.6) 51.4 (26.4) 0.001
Longer-term exclusive nutritional support (≥ 7 days)
Energy
Goal (kcal/kg) 25.6 (4.4) 25.9 (4.4) 24.8 (4.3) 0.166
Actual intake (kcal/kg) 17.5 (5.3) 17.7 (5.2) 16.9 (5.7) 0.389
Actual intake (% goal/kg) 68.7 (18.2) 68.8 (17.8) 68.2 (19.5) 0.857
Protein
Goal (g/kg) 1.19 (0.22) 1.20 (0.21) 1.15 (0.26) 0.281
Actual intake (g/kg) 0.77 (0.25) 0.79 (0.24) 0.71 (0.28) 0.125
Actual intake (% goal/kg) 64.8 (19.1) 66.1 (18.9) 61.6 (19.4) 0.206
Fig. 2 Bias-corrected calibration curve for the prediction of 28-day mortality
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whether the associations between the dose of energy and
protein intakes and mortality risk could be modified by
the baseline nutritional status of critically ill patients.
The GLIMPSE tool was developed because it was
hypothesized that baseline nutritional status and disease se-
verity could modify the association between the dose of en-
ergy and protein intakes and mortality risk. However, this
was not supported by the data in the current study. The
disparity between early high energy and protein intakes
and 28-day mortality in patients with short- and longer-
term ENS was unexpected, as was the lack of discrimin-
ation by the integration of nutritional status with disease
severity in the GLIMPSE model. Further stratification of
nutritional status in these two groups of patients also
revealed that the associations between energy and protein
intakes and 28-day mortality were independent of baseline
nutritional status (Table 4). The only overt differences
between patients with short- and longer-term ENS were
their exposure to surgery and the type of admission diagno-
sis, with patients who had short-term ENS being more
likely to be admitted for medical reasons and having a
higher incidence of cardiovascular or respiratory issues. In
contrast, a higher proportion of patients with longer-term
ENS were admitted with neurological diagnoses (Table 1).
Table 3 Characteristics of low- and high-GLIMPSE patients
Patient characteristics Low-GLIMPSE (n = 188) High-GLIMPSE (n = 252) p value
Age (years) 53.6 (16.0) 67.2 (12.8) < 0.001
Male 115 [61.2] 144 [57.1] 0.396
BMI (kg/m2) 25.5 (6.3) 24.9 (5.8) 0.262
Location before adm. < 0.001
ED/HD/OT 169 [89.9] 188 [74.6]
Wards 19 [10.1] 64 [25.4]
Type of adm. < 0.001
Medical 104 [55.3] 189 [75.0]
Surgery 84 [44.7] 63 [25.0]
Number of comorbidities 2.0 [1.0, 3.0] 3.0 [2.0, 4.0] < 0.001
LOS before ICU adm. (days) 0.0 [0.0. 1.0] 1.0 [0.0, 2.5] < 0.001
APACHE II 18.6 (5.2) 29.0 (6.9) < 0.001
SOFA 6.4 (3.0) 10.3 (3.4) < 0.001
mNUTRIC 3.4 (1.5) 6.7 (1.2) < 0.001
mNUTRIC≥ 5 (high-mNUTRIC) 55 [29.3] 244 [96.8] < 0.001
Malnutrition 29 [15.4] 94 [37.3] < 0.001
Predicted mortality risk 9.7 (5.0) 41.6 (19.5) < 0.001
Admission reasons < 0.001
Cardiovascular 22 [11.7] 60 [23.8]
Respiratory 39 [20.7] 45 [17.9]
Sepsis 26 [13.8] 79 [31.4]
Trauma 11 [5.9] 1 [0.4]
Metabolic/renal 3 [1.6] 5 [2.0]
Gastrointestinal 15 [8.0] 27 [10.7]
Postoperation 9 [4.8] 4 [1.6]
Orthopaedics 3 [1.6] 4 [1.6]
Neurological 60 [31.9] 27 [10.7]
CPR before ICU adm. 1 [0.5] 52 [20.6] < 0.001
Length of MV (days) 2.0 [1.0, 4.0] 2.0 [1.0, 5.0] 0.039
ICU LOS (days) 2.0 [2.0, 5.0] 3.0 [2.0, 5.0] 0.381
Hospital LOS (days) 13.5 [7.0, 27.0] 14.0 [7.0, 24.0] 0.953
Values are mean (standard deviation), median [Q1, Q3], or count [percentage]
Adm. admission, APACHE II Acute Physiology and Chronic Health Evaluation II, BMI body mass index, CPR cardiopulmonary resuscitation, ED emergency
department, ENS exclusive nutritional support, HD high dependency, ICU intensive care unit, LOS length of stay, MV mechanical ventilation, mNUTRIC Modified
Nutrition Risk in Critically Ill, OT operation theatre, SOFA Sequential Organ Failure Assessment
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One of the possible explanations for the results of our
study could be the metabolic state (i.e. catabolism vs.
anabolism) at the initial phase of nutritional support,
since this will dictate the fate of exogenous macronutri-
ent metabolism. Catabolism—During the acute phase of
critical illness, raised concentrations of glucagon, cate-
cholamines, and cortisol may result in anabolic resist-
ance [20]. Therefore, energy and protein provided at this
stage may not be effectively used for anabolism or
attenuation of catabolism (processes required to treat
malnutrition) [21–23]. This has been reported in recent
studies, where early high protein intake during the acute
phase of critical illness led to increased ureagenesis
(reflecting inefficiency in protein metabolism [24–27]).
Furthermore, early high energy and protein intakes were
associated with poorer clinical outcomes, such as pro-
longed ICU length of stay and increased risk of infection
[18] as well as a greater degree of muscle and functional
loss [22, 28, 29]. Mechanistically, these results may be
attributed to hindered autophagy [28, 30], attenuation of
the nonthyroidal illness syndrome [31] or intramuscular
inflammation, and altered hypoxic signalling, which con-
sequently reduces the bioavailability of the intramuscular
adenosine triphosphate needed for muscle protein syn-
thesis [29]. Anabolism—By contrast, during the later
phase of critical illness, inflammation and the levels of
hormones responsible for catabolism gradually abate;
this may result in more efficient use of energy and pro-
tein for anabolism and recovery [32].
The number, type, and degree of insults for each critic-
ally ill patient differ widely in the ICU. Therefore, some
patients will be in a prolonged catabolic state, whereas
others progress quickly into the anabolic phase (the later
stage of a critical illness) [32]. From the literature, it may
be deduced that the acute state can be as short as 3 days
[33] or as long as 7 days [34–36]. In the acute state, high
energy and protein intakes have been shown to worsen
clinical outcomes, whereas the same nutrient delivery at
Table 4 Association between energy and protein intakes and 28-day mortality as well as nutritional status stratified by days on
exclusive nutritional support and GLIMPSE groups
Parameters Short-term ENS (≤ 6 days) Longer-term ENS (≥ 7 days) p value
Low-GLIMPSE* (n = 36) High-GLIMPSE* (n = 70) Low-GLIMPSE* (n = 64) High-GLIMPSE* (n = 82)
Energy intake 0.793† 0.035‡
Each 10% of goal 1.24 (0.70–2.20) 1.60 (1.19–2.15) 2.17 (0.75–6.26) 0.83 (0.64–1.12)
p = 0.462 p = 0.002 p = 0.150 p = 0.228
GOF = 0.682 GOF = 0.823 GOF = 0.287 GOF = 0.615
Protein intake 0.904§ 0.025**
Each 10% of goal 1.20 (0.68–2.11) 1.47 (1.12–1.86) 1.23 (0.73–2.08) 0.75 (0.57–0.99)
p = 0.535 p = 0.004 p = 0.428 p = 0.043
GOF = 0.685 GOF = 0.530 GOF = 0.455 GOF = 0.335
7-point SGA-categories 0.480†† 0.633‡‡
Well-nourished
SGA-7 22 [61.1] 34 [48.6] 41 [64.1] 34 [41.5]
SGA-6 8 [22.2] 11 [15.7] 18 [28.1] 18 [22.0]
Mildly to moderately malnourished
SGA-5 3 [8.3] 8 [11.4] 4 [6.3] 14 [17.1]
SGA-4 2 [5.6] 7 [10.0] 1 [1.6] 9 [11.0]
SGA-3 1 [2.8] 5 [7.1] 0 [0.0] 5 [6.1]
Severely malnourished
SGA-2 4 [5.7] 2 [2.4]
SGA-1 1 [1.4] 0 [0.0]
Values are adjusted odds ratio (95% confidence interval) adjusted for days on exclusive nutritional support and count [percentage]. Refer to Additional file 1 for
beta weights of potential confounders not included in the model
ENS exclusive nutritional support, GLIMPSE Global Index of Mortality Probability in the Severely ill, GOF goodness of fit derived from Hosmer-Lemeshow test, SGA
Subjective Global Assessment
*Low- and high-GLIMPSE is defined as the predicted mortality risk of < 20% and > 20%, respectively
†Interaction between energy intake and GLIMPSE categories in patients with short-term exclusive nutritional support
‡Interaction between energy intake and GLIMPSE categories in patients with longer-term exclusive nutritional support
§Interaction between protein intake and GLIMPSE categories in patients with shorter-term exclusive nutritional support
**Interaction between protein intake and GLIMPSE categories in patients with longer-term exclusive nutritional support
††Comparison of 7-point SGA categories between low-GLIMPSE patients with short-term and longer-term ENS
‡‡Comparison of 7-point SGA categories between high-GLIMPSE patients with short-term and longer-term ENS
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the later stage has shown to have clinical benefits
[33–36]. Variability in the duration of the acute state
could explain the different effects of early high energy
and protein intakes in our study. That is, the positive
association between energy and protein intakes and
28-day mortality in high-GLIMPSE patients with
short-term ENS may reflect the consequence of early
high energy and protein intakes in an overt state of
catabolism, whereas the negative association in pa-
tients with longer-term ENS suggests an early reso-
lution of catabolism, and hence, energy and protein
could be efficiently used for anabolism. This hypoth-
esis could also explain why Compher et al. [6]
observed an inverse association between the dose of
nutrition support and mortality in patients with > 4
days of ENS - an observation congruent with patients
with longer-term ENS (≥ 7 days) in our study. The in-
clusion criteria used by Compher et al. [6] could in-
herently have selected patients who were somewhat in
the anabolic phase and hence benefited from higher
energy and protein intakes. Therefore, their findings
[6] may only apply to patients with > 4 days of ENS,
and the extrapolation of these results to recommend
early aggressive nutritional support to all severely ill
ICU patients may require caution.
The current study had a number of strengths. These
include consecutive recruitment and complete follow-
up, which minimised the selection and attrition biases.
In addition, we avoided an erroneous association
between minimal nutritional intake and mortality by
excluding moribund patients, since these patients inher-
ently have a minimal nutritional intake, and death
reflects disease severity. However, there were several
limitations. First, although GLIMPSE was found to have
good mortality prognostic performance, it was unable to
characterize the dynamic disease progression of critically
ill patients. For example, patients admitted with diabetic
ketoacidosis and severe pancreatitis may have identical
GLIMPSE scores, but the former would have a rapid
metabolic recovery, whereas the insult suffered by the
latter may worsen. Since GLIMPSE, along with other
prognostic scores, such as the mNUTRIC, are measured
once at day 2 of ICU admission, they are unable to
account for the differing pathophysiologies and disease
progressions under different conditions. Therefore,
future studies should collect covariates such as levels of
organ support and sequential SOFA score to adjust for
these time-dependent parameters. Second, the prognos-
tic accuracies of GLIMPSE were based on a single centre
with relatively small sample size, and larger multi-site
studies are required to more accurately estimate the
prognostic performance of the GLIMPSE model. Third,
as in all observational studies, the possibility of residual
confounding factors limited the interpretation of the
results in this study to the association rather than to the
causality. Lastly, nutritional status was not reassessed
during the course of ICU admission. Therefore, some
patients who were well-nourished at baseline may have
become malnourished during their stay in the ICU.
Future research and clinical implications
As the fate of nutrient metabolism during the acute and
later phases of critical illness is different, it is crucial for
future studies to identify the biomarkers that can accur-
ately define the duration of the different phases to better
guide nutritional support in the ICU [32]. Before this is
achieved, perhaps the timing and dose of energy and pro-
tein intakes should be guided by the surrogates of inflam-
mation resolution, e.g. down-trending of high-sensitivity
C-reactive protein, reduced insulin resistance (improved
glycaemic control in patients without diabetes [37]), or
improvement in organ functions (down-trending of the
sequential SOFA scores) [38] and levels of transthyretin
[39]. In addition, emerging evidence [10, 33, 34, 38, 39]
and recent guidelines [40] are supportive of progressive
provision of energy and protein during the first week of
ICU admission.
Conclusions
By integrating the predictors such as baseline nutritional
status and disease severity, the GLIMPSE model demon-
strated good prognostic performance in the prediction
of 28-day mortality in critically ill patients. However,
these predictors did not modify the association between
the dose of nutrition support during the first 6 days of
ENS and 28-day mortality. This suggests that the
mortality-modifying effects of nutritional support are
independent of the baseline nutritional status and dis-
ease severity of critically ill patients.
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